SEARCH RESULTS FOR: "Tag: VRX"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(19)
2017(92)
2016(180)
2015(51)
2014(4)
CATEGORIES
5-Minute Market Rundown(9)
Analyst Downgrades(33)
Analyst Update(18)
Analyst Upgrades(9)
Buzz Stocks(56)
By the Numbers(5)
Commodities(1)
Early Edge(1)
Earnings Preview(6)
Expectational Analysis(6)
Ezines(9)
General(7)
Indexes and ETFs(2)
Indicator of the Week(1)
Intraday Option Activity(42)
Market Recap(24)
Midday Market Check(38)
Most Active Options Update(9)
Most Active Weekly Options(8)
Opening View(44)
Quantitative Analysis(1)
Stock Market News(48)
Stocks On the Move(56)
Technical Analysis(2)
The Week Ahead(7)
Unusual Trading Activity(1)

6/18/2018 1:34 PM
The shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) are falling after recent Food and Drug Administration (FDA) notices. Specifically, the FDA decline...
6/5/2018 1:02 PM
Valeant Pharmaceuticals Intl Inc (NYSE:VRX), which will change its name to Bausch next month, is trading up 5.4% at $23.18, after an analyst at H.C. Wainwright said the drugmaker is becoming more fin...
5/15/2018 9:46 AM
Shares of drug name Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are trading higher this morning, after the stock received an upgrade from Mizuho to "buy" from "neutral" and a price-target hike to $27...
5/8/2018 11:56 AM
It's been a volatile day for stocks, with major equity indexes bouncing between positive and negative territory as investors anxiously await President Donald Trump's decision on whether or not to m...
5/8/2018 11:42 AM
Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are surging today -- up 15.9% to trade at $21.05, and on track for their best day since Nov. 7 -- after the drugmaker reported stronger-than-fore...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center